Main content

Froome’s adverse drugs test won't be resolved for a year - Hutchinson

Former cyclist Michael Hutchinson says Chris Froome’s adverse drugs test at the 2017 Vuelta a Espana will not be resolved for at least another year.

The Team Sky rider and Vuelta winner was found to have double the allowed level of legal asthma drug Salbutamol in his urine.

Briton Froome has not been suspended from competition, but the UCI has requested more details to explain the findings.

Speaking during the BeSpoke Weekly podcast, Hutchinson said a decision will not be made before the 2018 Giro d'Italia starting in May, and that it is more likely to be 2019 before the matter is resolved.

This clip was first broadcast during the BeSpoke Weekly podcast, Thursday 1 February 2018.

Release date:


2 minutes